Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1020]

The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 3: Lung Cancer

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 3: Lung Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 2: GU Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 2: GU Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

The 2022 OncoAlert Colloquium Day 1: Breast Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable...

Dr Ian Krop - Yale Cancer Center, Connecticut, USA

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previously treated with T-DM1 ( Dr Ian Krop - Yale Cancer Center, Connecticut, USA )

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk...

Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML ( Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA )

Comment: POLAR gene profile can identify which patients can safely avoid...

Prof Christos Markopoulos- National and Kapodistrian University of Athens...

Challenges and opportunities of integrative oncology as an effective tool to...

Dr Partha Basu - International Agency for Research on Cancer, Lyon, France

Challenges and opportunities of integrative oncology as an effective tool to enhance cancer prevention and treatment in LMICs. ( Dr Partha Basu - International Agency for Research on Cancer, Lyon, France )

UICC / WHO Policy dialogue: Maintaining cancer care in times of conflict and...

Michael Morrissey - European Cancer Organization, Brussels, Belgium

UICC / WHO Policy dialogue: Maintaining cancer care in times of conflict and environmental emergencies ( Michael Morrissey - European Cancer Organization, Brussels, Belgium )

Addressing women’s cancers: an economic evaluation of breast and cervical...

Dr Mary Nyangasi - Head of the National Cancer Control Programme, Nairobi, Kenya

Addressing women’s cancers: an economic evaluation of breast and cervical cancer interventions in Kenya ( Dr Mary Nyangasi - Head of the National Cancer Control Programme, Nairobi, Kenya )

Redefining cancer research priorities in the emerging context of the COVID-19...

Prof Richard Sullivan - King's College London, London, UK

Redefining cancer research priorities in the emerging context of the COVID-19 pandemic ( Prof Richard Sullivan - King's College London, London, UK )

Reducing social inequalities in cancer: Evidence and priorities for research

Dr Salvatore Vaccarella - International Agency for Research On Cancer, Lyon...

Reducing social inequalities in cancer: Evidence and priorities for research ( Dr Salvatore Vaccarella - International Agency for Research On Cancer, Lyon, France )

More from ecancer